Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1116-1123
JournalAmerican Journal of Neuroradiology
Volume36
Issue number6
DOIs
Publication statusPublished - 2015

Cite this

@article{1d060a87f124440bb8bed4c81a112437,
title = "Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis",
author = "O.T. Wiebenga and A.M. Klauser and M.M. Schoonheim and G.J.A. Nagtegaal and M.D. Steenwijk and {van Rossum}, J.A. and C.H. Polman and F. Barkhof and P.J.W. Pouwels and J.J.G. Geurts",
year = "2015",
doi = "10.3174/ajnr.A4252",
language = "Undefined/Unknown",
volume = "36",
pages = "1116--1123",
journal = "American Journal of Neuroradiology",
issn = "0195-6108",
publisher = "American Society of Neuroradiology",
number = "6",

}

TY - JOUR

T1 - Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis

AU - Wiebenga, O.T.

AU - Klauser, A.M.

AU - Schoonheim, M.M.

AU - Nagtegaal, G.J.A.

AU - Steenwijk, M.D.

AU - van Rossum, J.A.

AU - Polman, C.H.

AU - Barkhof, F.

AU - Pouwels, P.J.W.

AU - Geurts, J.J.G.

PY - 2015

Y1 - 2015

U2 - 10.3174/ajnr.A4252

DO - 10.3174/ajnr.A4252

M3 - Article

VL - 36

SP - 1116

EP - 1123

JO - American Journal of Neuroradiology

JF - American Journal of Neuroradiology

SN - 0195-6108

IS - 6

ER -